Flamma is a privately held, family run, family owned life science company with experience that dates back to its beginning in 1950. As a fully integrated small molecule CDMO, the Flamma Group offers a unique opportunity to accelerate your small molecules to the pharmaceutical marketplace. With the ability to leverage FDA inspected cGMP Italian production facilities along with 100% owned Chinese facilities (and now a cGMP site in the USA), Flamma provides a stable, secure supply chain for Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCEs), Registered Starting Materials (RSMs) and Key Intermediates. Flamma was awarded the maximum number of available CDMO Leadership Awards* for 2018 marking the 3^rd year in a row that it received such an honor. Flamma was recognized as a Top Performer in all 6 CDMO Core Award Categories: Expertise, Reliability, Capabilities, Quality, Service and Compatibility. Flamma was also recognized as a Top Performer in all 7 Specialty Award Categories for the 3^rd straight years. Those specialty categories are: Accessible Senior Management, State-of-the-Art, Innovation, On-Time Delivery, Right the First Time, Strength of Science, and Reputation. There were 110 CDMOs evaluated on 23 performance metrics by pharma industry sourcing professionals. Of these 110 CDMOs, Flamma was the ONLY small molecule CDMO that was rated as a TOP PERFORMER in all core & specialty categories.